These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Relationship between contrast medium dose and adverse effects in lumbar myelography. Wilmink JT; Lindeboom SF; Vencken LM; vd Burg W Diagn Imaging Clin Med; 1984; 53(4):208-14. PubMed ID: 6380885 [TBL] [Abstract][Full Text] [Related]
46. Persistent movement disorder following metrizamide myelography. Davis CE; Smith C; Harris R Arch Neurol; 1982 Feb; 39(2):128. PubMed ID: 7059297 [No Abstract] [Full Text] [Related]
47. [A case of metrizamide encephalopathy--a review of papers in respect of prevention and therapy against major side effects of metrizamide]. Takahashi T; Nakamura K; Tajima M No Shinkei Geka; 1983 Jul; 11(7):771-9. PubMed ID: 6621798 [No Abstract] [Full Text] [Related]
48. [Acute meningitis after metrizamide myelography. Unnecessary use of disinfectants]. Lingaas E Tidsskr Nor Laegeforen; 1985 Apr; 105(12):834. PubMed ID: 4012688 [No Abstract] [Full Text] [Related]
50. Akinesia and mutism following a methylphenidate challenge test. Wiener J; Kennedy S J Clin Psychopharmacol; 1985 Aug; 5(4):231-3. PubMed ID: 4019811 [TBL] [Abstract][Full Text] [Related]
51. Remarks about the paper by H.J. Gelmers: adverse side effects of metrizamide in myelography. Schmidt RC Neuroradiology; 1980; 19(2):111. PubMed ID: 7366835 [No Abstract] [Full Text] [Related]
52. Formed visual hallucinations after metrizamide myelography. Bachman DM Am J Ophthalmol; 1984 Jan; 97(1):78-81. PubMed ID: 6696024 [TBL] [Abstract][Full Text] [Related]
53. Hyperthermia after metrizamide myelography. Latack JT; Gabrielsen TO; Knake JE; Gebarski SS; Yang PJ AJNR Am J Neuroradiol; 1984; 5(5):649-51. PubMed ID: 6435437 [No Abstract] [Full Text] [Related]
55. [Cerebral convulsions after lumbar myelography with dimer X (further case studies)]. Prange H; Poser S Nervenarzt; 1977 Aug; 48(8):433-6. PubMed ID: 904759 [No Abstract] [Full Text] [Related]
56. Functional coma. Ludwig L; McWhirter L; Williams S; Derry C; Stone J Handb Clin Neurol; 2016; 139():313-327. PubMed ID: 27719852 [TBL] [Abstract][Full Text] [Related]
57. Diagnosis and rehabilitation strategies for patients with hysterical hemiparesis: a report of four cases. Watanabe TK; O'Dell MW; Togliatti TJ Arch Phys Med Rehabil; 1998 Jun; 79(6):709-14. PubMed ID: 9630154 [TBL] [Abstract][Full Text] [Related]
58. Conversion disorder presenting as hemiplegia and hemianesthesia with loss of neurologic reflexes: a case report. Hill E; Haydel M South Med J; 2006 Apr; 99(4):380-2. PubMed ID: 16634248 [TBL] [Abstract][Full Text] [Related]
59. Functional Coma: Two Case Reports and a Review of the Literature. Ryznar E; Wilcox D Psychosomatics; 2019; 60(4):343-351. PubMed ID: 31053419 [TBL] [Abstract][Full Text] [Related]
60. Placebo-induced conversion reaction: a neurobehavioral and EEG study of hysterical aphasia, seizure, and coma. Levy RS; Jankovic J J Abnorm Psychol; 1983 May; 92(2):243-9. PubMed ID: 6190852 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]